SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-23-031786
Filing Date
2023-07-05
Accepted
2023-07-05 17:42:39
Documents
1
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 6153
  Complete submission text file 0000950170-23-031786.txt   7747
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Issuer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INTERCEPT PHARMACEUTICALS, INC. 10 HUDSON YARDS, 37TH FL NEW YORK NY 10001
Business Address
Miller-Rich Nancy (Reporting) CIK: 0001735084 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36332 | Film No.: 231070961